$ Value
—
Shares
4,142
Price
—
Filed
Oct 31
Insider
Name
Basile Edward M
Title
—
CIK
0001773661
Roles
Transaction Details
Transaction Date
2025-10-29
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 6, 2024. | The option is fully vested. | The Stock Option reported herein as being disposed of is an option to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.
Filing Info
Basile Edward M's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-10-29 | TMDX | M | $3K |
| 2025-10-29 | TMDX | ▼ | $540K |
| 2025-10-29 | TMDX | M | — |
| 2025-08-04 | TMDX | M | $3K |
| 2025-08-04 | TMDX | ▼ | $520K |
| 2025-08-04 | TMDX | M | — |
| 2025-05-27 | TMDX | M | $4K |
| 2025-05-27 | TMDX | ▼ | $632K |
| 2025-05-27 | TMDX | M | — |
| 2025-05-22 | TMDX | A | $0 |
Other Insiders at TMDX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Lovell Stephanie | — | $178K | 2026-03-04 |
| Weill David | — | $524K | 2026-03-04 |
|
Corcoran Nicholas
See remarks
|
— | $413K | 2026-03-02 |
|
Ranganath Anil P.
See remarks
|
— | $120K | 2026-03-02 |
|
Hernandez Gerardo
Chief Financial Officer
|
— | $1.1M | 2026-03-04 |
|
Cecere Giovanni
Chief Commercial Officer
|
— | — | 2026-02-18 |